APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Iodinated X-Ray Contrast Media

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iodinated X-Ray Contrast Media Market Outlook and Growth Opportunities 2026

Report ID 174004390427 December 2025206 pages

Choose your research edition.

Industry ResearchIodinated X-Ray Contrast Media Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Iodinated X-Ray Contrast Media Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Iodinated X-Ray Contrast Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iodinated X-Ray Contrast Media Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Iodinated X-Ray Contrast Media Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Iodinated X-Ray Contrast Media market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iodinated X-Ray Contrast Media market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iodinated X-Ray Contrast Media market include Bayer, Bracco, Cadiasun Pharma GmbH, Daiichi Sankyo, Fuji Pharma, GE Healthcare, Grupo Juste, Guerbet and Imax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iodinated X-Ray Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iodinated X-Ray Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iodinated X-Ray Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iodinated X-Ray Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Iodinated X-Ray Contrast Media Segment by Company

Bayer

Bracco

Cadiasun Pharma GmbH

Daiichi Sankyo

Fuji Pharma

GE Healthcare

Grupo Juste

Guerbet

Imax

Liebel-Flarsheim Company LLC

Neptunus Bio-pharmaceutical

Takeda

BeiLu Pharma

Brilliant Pharmaceutical

Hengrui Pharmaceuticals

Consun Pharmaceutical

Shenghuaxi Pharmaceutical

YRPG

CTTQ

Iodinated X-Ray Contrast Media Segment by Type

Iodixanol

Iohexol

Ioversol

Iobitrol

Others

Iodinated X-Ray Contrast Media Segment by Application

Hospital

Clinic

Others

Iodinated X-Ray Contrast Media Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Iodinated X-Ray Contrast Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iodinated X-Ray Contrast Media market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iodinated X-Ray Contrast Media significant trends, drivers, influence factors in global and regions.

6. To analyze Iodinated X-Ray Contrast Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iodinated X-Ray Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iodinated X-Ray Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iodinated X-Ray Contrast Media.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iodinated X-Ray Contrast Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iodinated X-Ray Contrast Media industry.

Chapter 3: Detailed analysis of Iodinated X-Ray Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iodinated X-Ray Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iodinated X-Ray Contrast Media in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iodinated X-Ray Contrast Media Industry Trends Table 2. Iodinated X-Ray Contrast Media Industry Drivers Table 3. Iodinated X-Ray Contrast Media Industry Opportunities and Challenges Table 4. Iodinated X-Ray Contrast Media Industry Restraints Table 5. Global Iodinated X-Ray Contrast Media Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iodinated X-Ray Contrast Media Revenue Share by Company (2021-2026) Table 7. Global Iodinated X-Ray Contrast Media Sales Volume by Company (Units) & (2021-2026) Table 8. Global Iodinated X-Ray Contrast Media Sales Volume Share by Company (2021-2026) Table 9. Global Iodinated X-Ray Contrast Media Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Iodinated X-Ray Contrast Media Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iodinated X-Ray Contrast Media Key Company Manufacturing Base & Headquarters Table 12. Global Iodinated X-Ray Contrast Media Company, Product Type & Application Table 13. Global Iodinated X-Ray Contrast Media Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iodinated X-Ray Contrast Media by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Iodixanol Table 18. Significant Companies of Iohexol Table 19. Significant Companies of Ioversol Table 20. Significant Companies of Iobitrol Table 21. Significant Companies of Others Table 22. Global Iodinated X-Ray Contrast Media Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 23. Global Iodinated X-Ray Contrast Media Sales Volume by Type (2021-2026) & (Units) Table 24. Global Iodinated X-Ray Contrast Media Sales Volume by Type (2027-2032) & (Units) Table 25. Global Iodinated X-Ray Contrast Media Sales Volume Share by Type (2021-2026) Table 26. Global Iodinated X-Ray Contrast Media Sales Volume Share by Type (2027-2032) Table 27. Global Iodinated X-Ray Contrast Media Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Iodinated X-Ray Contrast Media Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Iodinated X-Ray Contrast Media Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Iodinated X-Ray Contrast Media Sales Value Share by Type (2021-2026) Table 31. Global Iodinated X-Ray Contrast Media Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Iodinated X-Ray Contrast Media Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Iodinated X-Ray Contrast Media Sales Volume by Application (2021-2026) & (Units) Table 37. Global Iodinated X-Ray Contrast Media Sales Volume by Application (2027-2032) & (Units) Table 38. Global Iodinated X-Ray Contrast Media Sales Volume Share by Application (2021-2026) Table 39. Global Iodinated X-Ray Contrast Media Sales Volume Share by Application (2027-2032) Table 40. Global Iodinated X-Ray Contrast Media Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Iodinated X-Ray Contrast Media Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Iodinated X-Ray Contrast Media Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Iodinated X-Ray Contrast Media Sales Value Share by Application (2021-2026) Table 44. Global Iodinated X-Ray Contrast Media Sales Value Share by Application (2027-2032) Table 45. Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Iodinated X-Ray Contrast Media Sales by Region (2021-2026) & (Units) Table 47. Global Iodinated X-Ray Contrast Media Sales Market Share by Region (2021-2026) Table 48. Global Iodinated X-Ray Contrast Media Sales by Region (2027-2032) & (Units) Table 49. Global Iodinated X-Ray Contrast Media Sales Market Share by Region (2027-2032) Table 50. Global Iodinated X-Ray Contrast Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Iodinated X-Ray Contrast Media Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Iodinated X-Ray Contrast Media Sales Value Share by Region (2021-2026) Table 53. Global Iodinated X-Ray Contrast Media Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Iodinated X-Ray Contrast Media Sales Value Share by Region (2027-2032) Table 55. Global Iodinated X-Ray Contrast Media Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Iodinated X-Ray Contrast Media Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Iodinated X-Ray Contrast Media Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global Iodinated X-Ray Contrast Media Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Iodinated X-Ray Contrast Media Sales by Country (2021-2026) & (Units) Table 60. Global Iodinated X-Ray Contrast Media Sales Market Share by Country (2021-2026) Table 61. Global Iodinated X-Ray Contrast Media Sales by Country (2027-2032) & (Units) Table 62. Global Iodinated X-Ray Contrast Media Sales Market Share by Country (2027-2032) Table 63. Global Iodinated X-Ray Contrast Media Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Iodinated X-Ray Contrast Media Sales Value Market Share by Country (2021-2026) Table 65. Global Iodinated X-Ray Contrast Media Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Iodinated X-Ray Contrast Media Sales Value Market Share by Country (2027-2032) Table 67. Bayer Company Information Table 68. Bayer Business Overview Table 69. Bayer Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bayer Iodinated X-Ray Contrast Media Product Portfolio Table 71. Bayer Recent Development Table 72. Bracco Company Information Table 73. Bracco Business Overview Table 74. Bracco Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bracco Iodinated X-Ray Contrast Media Product Portfolio Table 76. Bracco Recent Development Table 77. Cadiasun Pharma GmbH Company Information Table 78. Cadiasun Pharma GmbH Business Overview Table 79. Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Portfolio Table 81. Cadiasun Pharma GmbH Recent Development Table 82. Daiichi Sankyo Company Information Table 83. Daiichi Sankyo Business Overview Table 84. Daiichi Sankyo Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Daiichi Sankyo Iodinated X-Ray Contrast Media Product Portfolio Table 86. Daiichi Sankyo Recent Development Table 87. Fuji Pharma Company Information Table 88. Fuji Pharma Business Overview Table 89. Fuji Pharma Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Fuji Pharma Iodinated X-Ray Contrast Media Product Portfolio Table 91. Fuji Pharma Recent Development Table 92. GE Healthcare Company Information Table 93. GE Healthcare Business Overview Table 94. GE Healthcare Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GE Healthcare Iodinated X-Ray Contrast Media Product Portfolio Table 96. GE Healthcare Recent Development Table 97. Grupo Juste Company Information Table 98. Grupo Juste Business Overview Table 99. Grupo Juste Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Grupo Juste Iodinated X-Ray Contrast Media Product Portfolio Table 101. Grupo Juste Recent Development Table 102. Guerbet Company Information Table 103. Guerbet Business Overview Table 104. Guerbet Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Guerbet Iodinated X-Ray Contrast Media Product Portfolio Table 106. Guerbet Recent Development Table 107. Imax Company Information Table 108. Imax Business Overview Table 109. Imax Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Imax Iodinated X-Ray Contrast Media Product Portfolio Table 111. Imax Recent Development Table 112. Liebel-Flarsheim Company LLC Company Information Table 113. Liebel-Flarsheim Company LLC Business Overview Table 114. Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Portfolio Table 116. Liebel-Flarsheim Company LLC Recent Development Table 117. Neptunus Bio-pharmaceutical Company Information Table 118. Neptunus Bio-pharmaceutical Business Overview Table 119. Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 121. Neptunus Bio-pharmaceutical Recent Development Table 122. Takeda Company Information Table 123. Takeda Business Overview Table 124. Takeda Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Takeda Iodinated X-Ray Contrast Media Product Portfolio Table 126. Takeda Recent Development Table 127. BeiLu Pharma Company Information Table 128. BeiLu Pharma Business Overview Table 129. BeiLu Pharma Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. BeiLu Pharma Iodinated X-Ray Contrast Media Product Portfolio Table 131. BeiLu Pharma Recent Development Table 132. Brilliant Pharmaceutical Company Information Table 133. Brilliant Pharmaceutical Business Overview Table 134. Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 136. Brilliant Pharmaceutical Recent Development Table 137. Hengrui Pharmaceuticals Company Information Table 138. Hengrui Pharmaceuticals Business Overview Table 139. Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Portfolio Table 141. Hengrui Pharmaceuticals Recent Development Table 142. Consun Pharmaceutical Company Information Table 143. Consun Pharmaceutical Business Overview Table 144. Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 146. Consun Pharmaceutical Recent Development Table 147. Shenghuaxi Pharmaceutical Company Information Table 148. Shenghuaxi Pharmaceutical Business Overview Table 149. Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio Table 151. Shenghuaxi Pharmaceutical Recent Development Table 152. YRPG Company Information Table 153. YRPG Business Overview Table 154. YRPG Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. YRPG Iodinated X-Ray Contrast Media Product Portfolio Table 156. YRPG Recent Development Table 157. CTTQ Company Information Table 158. CTTQ Business Overview Table 159. CTTQ Iodinated X-Ray Contrast Media Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. CTTQ Iodinated X-Ray Contrast Media Product Portfolio Table 161. CTTQ Recent Development Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Iodinated X-Ray Contrast Media Distributors List Table 165. Iodinated X-Ray Contrast Media Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Iodinated X-Ray Contrast Media Product Image Figure 2. Global Iodinated X-Ray Contrast Media Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iodinated X-Ray Contrast Media Sales (2021-2032) & (Units) Figure 5. Global Iodinated X-Ray Contrast Media Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Iodinated X-Ray Contrast Media Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Iodixanol Image Figure 10. Iohexol Image Figure 11. Ioversol Image Figure 12. Iobitrol Image Figure 13. Others Image Figure 14. Global Iodinated X-Ray Contrast Media Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global Iodinated X-Ray Contrast Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Iodinated X-Ray Contrast Media Sales Volume Share by Type (2021-2032) Figure 17. Global Iodinated X-Ray Contrast Media Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Iodinated X-Ray Contrast Media Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Iodinated X-Ray Contrast Media Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Iodinated X-Ray Contrast Media Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Iodinated X-Ray Contrast Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Iodinated X-Ray Contrast Media Sales Volume Share by Application (2021-2032) Figure 26. Global Iodinated X-Ray Contrast Media Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Iodinated X-Ray Contrast Media Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Iodinated X-Ray Contrast Media Sales Value Share by Application (2021-2032) Figure 29. Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global Iodinated X-Ray Contrast Media Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Iodinated X-Ray Contrast Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Iodinated X-Ray Contrast Media Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 34. North America Iodinated X-Ray Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Iodinated X-Ray Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Iodinated X-Ray Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 40. South America Iodinated X-Ray Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Iodinated X-Ray Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Iodinated X-Ray Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Iodinated X-Ray Contrast Media Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Iodinated X-Ray Contrast Media Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Iodixanol
  • Iohexol
  • Ioversol
  • Iobitrol
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bayer
  • Bracco
  • Cadiasun Pharma GmbH
  • Daiichi Sankyo
  • Fuji Pharma
  • GE Healthcare
  • Grupo Juste
  • Guerbet
  • Imax
  • Liebel-Flarsheim Company LLC
  • Neptunus Bio-pharmaceutical
  • Takeda
  • BeiLu Pharma
  • Brilliant Pharmaceutical
  • Hengrui Pharmaceuticals
  • Consun Pharmaceutical
  • Shenghuaxi Pharmaceutical
  • YRPG
  • CTTQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  4. 1.2.2 Global Iodinated X-Ray Contrast Media Sales Volume (2021-2032)
  5. 1.2.3 Global Iodinated X-Ray Contrast Media Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iodinated X-Ray Contrast Media Market Dynamics
  1. 2.1 Iodinated X-Ray Contrast Media Industry Trends
  2. 2.2 Iodinated X-Ray Contrast Media Industry Drivers
  3. 2.3 Iodinated X-Ray Contrast Media Industry Opportunities and Challenges
  4. 2.4 Iodinated X-Ray Contrast Media Industry Restraints
3 Iodinated X-Ray Contrast Media Market by Company
  1. 3.1 Global Iodinated X-Ray Contrast Media Company Revenue Ranking in 2025
  2. 3.2 Global Iodinated X-Ray Contrast Media Revenue by Company (2021-2026)
  3. 3.3 Global Iodinated X-Ray Contrast Media Sales Volume by Company (2021-2026)
  4. 3.4 Global Iodinated X-Ray Contrast Media Average Price by Company (2021-2026)
  5. 3.5 Global Iodinated X-Ray Contrast Media Company Ranking (2024-2026)
  6. 3.6 Global Iodinated X-Ray Contrast Media Company Manufacturing Base and Headquarters
  7. 3.7 Global Iodinated X-Ray Contrast Media Company Product Type and Application
  8. 3.8 Global Iodinated X-Ray Contrast Media Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iodinated X-Ray Contrast Media Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iodinated X-Ray Contrast Media Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iodinated X-Ray Contrast Media Market by Type
  1. 4.1 Iodinated X-Ray Contrast Media Type Introduction
  2. 4.1.1 Iodixanol
  3. 4.1.2 Iohexol
  4. 4.1.3 Ioversol
  5. 4.1.4 Iobitrol
  6. 4.1.5 Others
  7. 4.2 Global Iodinated X-Ray Contrast Media Sales Volume by Type
  8. 4.2.1 Global Iodinated X-Ray Contrast Media Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Iodinated X-Ray Contrast Media Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Iodinated X-Ray Contrast Media Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Iodinated X-Ray Contrast Media Sales Value by Type
  12. 4.3.1 Global Iodinated X-Ray Contrast Media Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Iodinated X-Ray Contrast Media Sales Value by Type (2021-2032)
  14. 4.3.3 Global Iodinated X-Ray Contrast Media Sales Value Share by Type (2021-2032)
5 Iodinated X-Ray Contrast Media Market by Application
  1. 5.1 Iodinated X-Ray Contrast Media Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Iodinated X-Ray Contrast Media Sales Volume by Application
  6. 5.2.1 Global Iodinated X-Ray Contrast Media Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Iodinated X-Ray Contrast Media Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Iodinated X-Ray Contrast Media Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Iodinated X-Ray Contrast Media Sales Value by Application
  10. 5.3.1 Global Iodinated X-Ray Contrast Media Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Iodinated X-Ray Contrast Media Sales Value by Application (2021-2032)
  12. 5.3.3 Global Iodinated X-Ray Contrast Media Sales Value Share by Application (2021-2032)
6 Iodinated X-Ray Contrast Media Regional Sales and Value Analysis
  1. 6.1 Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iodinated X-Ray Contrast Media Sales by Region (2021-2032)
  3. 6.2.1 Global Iodinated X-Ray Contrast Media Sales by Region: 2021-2026
  4. 6.2.2 Global Iodinated X-Ray Contrast Media Sales by Region (2027-2032)
  5. 6.3 Global Iodinated X-Ray Contrast Media Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iodinated X-Ray Contrast Media Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iodinated X-Ray Contrast Media Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iodinated X-Ray Contrast Media Sales Value by Region (2027-2032)
  9. 6.5 Global Iodinated X-Ray Contrast Media Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  12. 6.6.2 North America Iodinated X-Ray Contrast Media Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  15. 6.7.2 Europe Iodinated X-Ray Contrast Media Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iodinated X-Ray Contrast Media Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  21. 6.9.2 South America Iodinated X-Ray Contrast Media Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iodinated X-Ray Contrast Media Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iodinated X-Ray Contrast Media Sales Value Share by Country, 2025 VS 2032
7 Iodinated X-Ray Contrast Media Country-level Sales and Value Analysis
  1. 7.1 Global Iodinated X-Ray Contrast Media Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iodinated X-Ray Contrast Media Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
  4. 7.3.1 Global Iodinated X-Ray Contrast Media Sales by Country (2021-2026)
  5. 7.3.2 Global Iodinated X-Ray Contrast Media Sales by Country (2027-2032)
  6. 7.4 Global Iodinated X-Ray Contrast Media Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iodinated X-Ray Contrast Media Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iodinated X-Ray Contrast Media Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iodinated X-Ray Contrast Media Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iodinated X-Ray Contrast Media Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iodinated X-Ray Contrast Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Iodinated X-Ray Contrast Media Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Bracco
  8. 8.2.1 Bracco Company Information
  9. 8.2.2 Bracco Business Overview
  10. 8.2.3 Bracco Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Iodinated X-Ray Contrast Media Product Portfolio
  12. 8.2.5 Bracco Recent Developments
  13. 8.3 Cadiasun Pharma GmbH
  14. 8.3.1 Cadiasun Pharma GmbH Company Information
  15. 8.3.2 Cadiasun Pharma GmbH Business Overview
  16. 8.3.3 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Portfolio
  18. 8.3.5 Cadiasun Pharma GmbH Recent Developments
  19. 8.4 Daiichi Sankyo
  20. 8.4.1 Daiichi Sankyo Company Information
  21. 8.4.2 Daiichi Sankyo Business Overview
  22. 8.4.3 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Daiichi Sankyo Iodinated X-Ray Contrast Media Product Portfolio
  24. 8.4.5 Daiichi Sankyo Recent Developments
  25. 8.5 Fuji Pharma
  26. 8.5.1 Fuji Pharma Company Information
  27. 8.5.2 Fuji Pharma Business Overview
  28. 8.5.3 Fuji Pharma Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fuji Pharma Iodinated X-Ray Contrast Media Product Portfolio
  30. 8.5.5 Fuji Pharma Recent Developments
  31. 8.6 GE Healthcare
  32. 8.6.1 GE Healthcare Company Information
  33. 8.6.2 GE Healthcare Business Overview
  34. 8.6.3 GE Healthcare Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GE Healthcare Iodinated X-Ray Contrast Media Product Portfolio
  36. 8.6.5 GE Healthcare Recent Developments
  37. 8.7 Grupo Juste
  38. 8.7.1 Grupo Juste Company Information
  39. 8.7.2 Grupo Juste Business Overview
  40. 8.7.3 Grupo Juste Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Grupo Juste Iodinated X-Ray Contrast Media Product Portfolio
  42. 8.7.5 Grupo Juste Recent Developments
  43. 8.8 Guerbet
  44. 8.8.1 Guerbet Company Information
  45. 8.8.2 Guerbet Business Overview
  46. 8.8.3 Guerbet Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guerbet Iodinated X-Ray Contrast Media Product Portfolio
  48. 8.8.5 Guerbet Recent Developments
  49. 8.9 Imax
  50. 8.9.1 Imax Company Information
  51. 8.9.2 Imax Business Overview
  52. 8.9.3 Imax Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Imax Iodinated X-Ray Contrast Media Product Portfolio
  54. 8.9.5 Imax Recent Developments
  55. 8.10 Liebel-Flarsheim Company LLC
  56. 8.10.1 Liebel-Flarsheim Company LLC Company Information
  57. 8.10.2 Liebel-Flarsheim Company LLC Business Overview
  58. 8.10.3 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Portfolio
  60. 8.10.5 Liebel-Flarsheim Company LLC Recent Developments
  61. 8.11 Neptunus Bio-pharmaceutical
  62. 8.11.1 Neptunus Bio-pharmaceutical Company Information
  63. 8.11.2 Neptunus Bio-pharmaceutical Business Overview
  64. 8.11.3 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  66. 8.11.5 Neptunus Bio-pharmaceutical Recent Developments
  67. 8.12 Takeda
  68. 8.12.1 Takeda Company Information
  69. 8.12.2 Takeda Business Overview
  70. 8.12.3 Takeda Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Takeda Iodinated X-Ray Contrast Media Product Portfolio
  72. 8.12.5 Takeda Recent Developments
  73. 8.13 BeiLu Pharma
  74. 8.13.1 BeiLu Pharma Company Information
  75. 8.13.2 BeiLu Pharma Business Overview
  76. 8.13.3 BeiLu Pharma Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BeiLu Pharma Iodinated X-Ray Contrast Media Product Portfolio
  78. 8.13.5 BeiLu Pharma Recent Developments
  79. 8.14 Brilliant Pharmaceutical
  80. 8.14.1 Brilliant Pharmaceutical Company Information
  81. 8.14.2 Brilliant Pharmaceutical Business Overview
  82. 8.14.3 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  84. 8.14.5 Brilliant Pharmaceutical Recent Developments
  85. 8.15 Hengrui Pharmaceuticals
  86. 8.15.1 Hengrui Pharmaceuticals Company Information
  87. 8.15.2 Hengrui Pharmaceuticals Business Overview
  88. 8.15.3 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Portfolio
  90. 8.15.5 Hengrui Pharmaceuticals Recent Developments
  91. 8.16 Consun Pharmaceutical
  92. 8.16.1 Consun Pharmaceutical Company Information
  93. 8.16.2 Consun Pharmaceutical Business Overview
  94. 8.16.3 Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  96. 8.16.5 Consun Pharmaceutical Recent Developments
  97. 8.17 Shenghuaxi Pharmaceutical
  98. 8.17.1 Shenghuaxi Pharmaceutical Company Information
  99. 8.17.2 Shenghuaxi Pharmaceutical Business Overview
  100. 8.17.3 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
  102. 8.17.5 Shenghuaxi Pharmaceutical Recent Developments
  103. 8.18 YRPG
  104. 8.18.1 YRPG Company Information
  105. 8.18.2 YRPG Business Overview
  106. 8.18.3 YRPG Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 YRPG Iodinated X-Ray Contrast Media Product Portfolio
  108. 8.18.5 YRPG Recent Developments
  109. 8.19 CTTQ
  110. 8.19.1 CTTQ Company Information
  111. 8.19.2 CTTQ Business Overview
  112. 8.19.3 CTTQ Iodinated X-Ray Contrast Media Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 CTTQ Iodinated X-Ray Contrast Media Product Portfolio
  114. 8.19.5 CTTQ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iodinated X-Ray Contrast Media Value Chain Analysis
  2. 9.1.1 Iodinated X-Ray Contrast Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iodinated X-Ray Contrast Media Sales Mode & Process
  6. 9.2 Iodinated X-Ray Contrast Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iodinated X-Ray Contrast Media Distributors
  9. 9.2.3 Iodinated X-Ray Contrast Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst